Teradyne Results Reflect Expectations Issue, Not a Miss: Morgan Stanley
Morgan Stanley analyst says Teradyne (TER) results reflect an 'expectations issue' rather than a miss, as investor optimism around AI networking was overblown. The analyst lowered the price target to $145 from $160 while maintaining an Overweight rating.
Teradyne: An Expectations Issue, Not a Miss
Morgan Stanley analyst said Teradyne's (TER) quarterly results reflect an 'expectations issue' rather than a miss, as investor optimism around AI networking prospects was overdone. The analyst lowered the price target on Teradyne shares to $145 from $160, while keeping an Overweight rating.
Rating Change
- Previous Rating: Overweight
- Current Rating: Overweight
- Previous Price Target: $160
- New Price Target: $145
Analyst's Rationale
The analyst noted that Teradyne's Q4 results were in line with revised expectations, but the market had anticipated stronger performance in the AI networking segment. The company faces challenges in achieving expected growth in this area due to slowing demand from some key customers.
Context
The revision comes after Teradyne reported Q4 2025 results with revenue of $1.2 billion, down 3% year-over-year. The stock fell about 5% in after-hours trading following the release.
What to Make of It
Despite the price target cut, Morgan Stanley believes Teradyne still has strong fundamentals in the semiconductor test market, but overly optimistic AI networking expectations need recalibration. Investors should closely monitor demand trends in this segment.
Frequently Asked Questions
Found this useful? Share it